3rki
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='3rki' size='340' side='right'caption='[[3rki]], [[Resolution|resolution]] 3.20Å' scene=''> | <StructureSection load='3rki' size='340' side='right'caption='[[3rki]], [[Resolution|resolution]] 3.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3rki]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3rki]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_orthopneumovirus Human orthopneumovirus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3RKI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3RKI FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.2Å</td></tr> |
- | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3rki FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3rki OCA], [https://pdbe.org/3rki PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3rki RCSB], [https://www.ebi.ac.uk/pdbsum/3rki PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3rki ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3rki FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3rki OCA], [https://pdbe.org/3rki PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3rki RCSB], [https://www.ebi.ac.uk/pdbsum/3rki PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3rki ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/FUS_HRSVA FUS_HRSVA] Class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the heptad repeat (HR) regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and plasma cell membranes. Directs fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. This fusion is pH independent and occurs directly at the outer cell membrane. The trimer of F1-F2 (protein F) interacts with glycoprotein G at the virion surface. Upon binding of G to heparan sulfate, the hydrophobic fusion peptide is unmasked and interacts with the cellular membrane, inducing the fusion between host cell and virion membranes. Notably, RSV fusion protein is able to interact directly with heparan sulfate and therefore actively participates in virus attachment. Furthermore, the F2 subunit was identifed as the major determinant of RSV host cell specificity. Later in infection, proteins F expressed at the plasma membrane of infected cells mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis. The fusion protein is also able to trigger p53-dependent apoptosis.<ref>PMID:12663767</ref> <ref>PMID:18216092</ref> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Human orthopneumovirus]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Carfi | + | [[Category: Carfi A]] |
- | [[Category: Dey | + | [[Category: Dey AK]] |
- | [[Category: Dormitzer | + | [[Category: Dormitzer PD]] |
- | [[Category: Mandl | + | [[Category: Mandl CW]] |
- | [[Category: Rappuoli | + | [[Category: Rappuoli R]] |
- | [[Category: Settembre | + | [[Category: Settembre EC]] |
- | [[Category: Shaw | + | [[Category: Shaw CA]] |
- | [[Category: Swanson | + | [[Category: Swanson KA]] |
- | + | ||
- | + |
Revision as of 12:27, 14 March 2024
Structural basis for immunization with post-fusion RSV F to elicit high neutralizing antibody titers
|